Pilot and Feasibility Award Program

2016 Pilot and Feasibility Awards of the Stanford DRC

Based on our recent Pilot and Feasibility request for applications we received 37 applications. On behalf of the Stanford Diabetes Research Center, congratulations to the 2016 Stanford DRC P&F award recipients!

The Stanford Diabetes Research Center is committed to providing support for original research related to diabetes in all disciplines. Our goal is to support, enhance and foster new ideas that will improve how we understand, diagnose, treat and care for diabetes and its complications. The P&F program is a DRC hallmark designed to meet this goal. 

The submitted proposals were from multiple disciplines representing a wide range of biology and clinical medicine. These included proposals from investigators in the Departments of Medicine, Pediatrics, Psychiatry and Behavioral Sciences, Surgery, Obstetrics and Gynecology, Radiology, Ophthalmology, Pathology, Anesthesiology, the Cardiovascular Institute, Genetics, Bioengineering, Microbiology and Immunology, Chemical Systems Biology and Molecular & Cellular Physiology. A total of ten proposals were selected for funding from this year's P&F competition, six with funds from the DRC and four by DRC arrangements with CVI Seed Program. We anticipate another P&F competition in the autumn of 2017; please watch for the Request for Applications.

Thank you to all for your submissions, and congratulations again to this year's awardees.

Vivek Bhalla MD | Assistant Professor of Medicine (Nephrology)
Collaborators: Michael Snyder, PhD, Latha Palaniappan, MD
"Validation of cell-free RNA associated with human diabetic kidney disease"

Jennifer Cochran PhD | Associate Professor of Bioengineering, and by courtesy, of Chemical Engineering
"Engineering agonists of the glucagon-like peptide-1 receptor with novel pharmacological properties for the study and therapeutic control of diabetes"

Eric Gross, MD | Assistant Professor of Anesthesiology, Perioperative and Pain Medicine
"Generation of endothelial cells resistant to hyperglycemia-induced endothelial cell dysfunction"

Won Hee Lee, PhD | Instructor, Cardiovascular Institute Collaborators: Kari Nadeau, PhD, Sang Ging Ong, PhD
"Assessing the potential health risk of e-cigarettes in diabetes"

Joyce Liao, MD PhD | Assistant Professor of Ophthalmology
Collaborator: Cornelia Weyand, MD PhD
"Treatment of vision loss due to optic nerve ischemia in diabetes"

Elena Matsa, PhD | Instructor, Cardiovascular Institue
Collaborators: Kenneth Mahaffey MD, Michael P. Snyder, PhD
"Identification of genetic variation determining patient-specific responses to anti-diabetic drugs"

Tracey McLaughlin, MD | Associate Professor of Medicine (Endocrinology)
Collaborators: Nazish Sayed, MD, PhD, Ian Chen, MD, PhD
"Predicting Cardiovascular Benefits of Anti-diabetic Drugs"

Nadine Nagy, PhD | Instructor, Department of Medicine
Collaborators: Paul Bollyky MD, PhD, Adam Frymoyer, MD, Jayakumar Rajadas, PhD
"The development of 4-methylumbelliferone analogs to prevent autoimmune diabetes"

Diana Naranjo, MD | Research Assistant Professor, Psychiatry and Behavioral Sciences
Collaborator: Korey Hood, PhD
"Optimizing uptake and use of closed loop automated insulin delivery systems through virtual reality"

Mary Teruel, PhD | Assistant Professor, Chemical Systems Biology
Collaborator: Rajat Roatgi, MD
"Understanding the role of FABP4 in regulating adipogenesis and adipocyte function"

Frederic Kraemer Chief of the Division of Endocrinology, Gerontology, and Metabolism fbk@stanford.edu

Frederic Kraemer

Chief of the Division of Endocrinology, Gerontology, and Metabolism


Fredric B. Kraemer, M.D. receiving his Bachelor's degree in Chemistry from Emory University in 1970 and his M.D. from New York University in 1974. He was a house officer in Internal Medicine at Kings County/Downstate Medical Center (1974-1978) and a postdoctoral fellow in Endocrinology at Stanford University (1978-1982). He joined the faculty in the Department of Medicine at Stanford in 1983, with an appointment at the Palo Alto VA Hospital in 1988. Dr. Kraemer currently holds the Stanford University Professorship in Endocinology and is the Chief of the Divison of Endocrinology, Gerontology and Metabolism, as well as a staff physician at the VA Palo Alto Health Care System. He was Associate Chief of Staff for Research and Development at the VA Palo Alto Health Care System from 2002-2007. His clinical and research interests have been focused on diabetes and cellular lipid metabolism. Dr. Kraemer's research program has been supported throughout his career by grants from the NIH and the Department of Veterans Affairs. He has won several awards including a Special Emphasis Research Career Award from the NIH, a SmithKline Beecham Junior Faculty Award in Diabetes, and an Arteriosclerosis Special Recognition Award from the Council on Arteriosclerosis, Thrombosis and Vascular Biology of the American Heart Association. Dr. Kraemer has served as president of the Western States Affiliate of the American Hearth Association, on the Scientific Advisory Committee of the University of California Tobacco-Related Disease Program, and the University of Minnesota Obesity Center, and the Advisory Board of the Deuel Conference on Lipids. In addition, he has served on a number of grant review boards for VA, NIH, American Diabetes Association and American Heart Association.